Moreover, it has been demonstrated that leptin can be a co-factor for TGF-β in cancer using an in vitro model of kidney fibroblasts whereby leptin treatment enhances SMAD2/3 phosphorylation by TGF-β32,33. Here, SMAD2 is linked to cancer.